Nateglinide
Starlix (nateglinide) is a small molecule pharmaceutical. Nateglinide was first approved as Starlix on 2000-12-22. It is used to treat type 2 diabetes mellitus in the USA. It has been approved in Europe to treat type 2 diabetes mellitus.
| Trade Name | Starlix |
|---|---|
| Common Name | Nateglinide |
| Indication | type 2 diabetes mellitus |
| Drug Class | Antidiabetic, SGLT2 inhibitors, not phlorozin derivatives |
